Natco Pharma Limited is a vertically integrated and R&D-focused pharmaceutical company engaged in developing, manufacturing, and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). Their focus is primarily on niche therapeutic areas and complex products. They market and distribute their products in over 40 countries and sell their FDF products in the United States, India, Europe, and the rest of the world. They manufacture API products that are primarily used for captive consumption in their FDF products and are also sold to customers for various international markets such as Brazil, Europe, and the USA. In the API segment, they have capabilities to develop and manufacture products with multi-step synthesis, semi-synthetic fusion technologies, high-potency APIs, and peptides.